Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis

Wenink, M.H., Santegoets, K.C.M., Butcher, J., van Bon, L., Lamers-Karnebeek, F.G.M., van den Berg, W.B., van Riel, P.L.C.M., McInnes, I.B. and Radstake, T.R.D.J. (2011) Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis. Arthritis and Rheumatism, 63(11), pp. 3313-3322. (doi:10.1002/art.30577) (PMID:21811995)

Full text not currently available from Enlighten.

Abstract

Objective: The pathogenesis of psoriatic arthritis (PsA) remains poorly understood. The underlying chronic inflammatory immune response is thought to be triggered by unknown environmental factors potentially arising from a defective immune function. We undertook this study to determine whether an impaired acute inflammatory response by dendritic cells (DCs) might compromise the clearance of bacteria and predispose to chronic inflammation.

Methods: We determined cytokine production by DCs from healthy controls and from patients with rheumatoid arthritis, PsA, and psoriasis in response to Mycobacterium tuberculosis, Mycobacterium avium paratuberculosis, and a range of other bacteria and Toll-like receptor (TLR) ligands. Phenotypic differences involved in cellular responses against (myco) bacteria were determined by quantitative polymerase chain reaction and flow cytometry.

Results: The secretion of proinflammatory cytokines by PsA DCs was impaired upon in vitro challenge with mycobacteria and TLR-2 ligands. This impairment was associated with elevated serum levels of C-reactive protein. The expression of TLR-2 and other receptors known to mediate mycobacterial recognition was unaltered. In contrast, the intracellular TLR inhibitors suppressor of cytokine signaling 3 and A20 were more highly expressed in DCs from PsA patients. PsA DCs further demonstrated up-regulated levels of ATG16L1, NADPH oxidase 2, and LL37, which are molecules implicated in the immune response against intracellular bacteria.

Conclusion: Our findings indicate that DCs from PsA patients have a disordered immune response toward some species of (myco) bacteria. This might predispose to impaired immune responses to, and in turn impaired clearance of, these bacteria, setting the stage for the chronic inflammation of joints, entheses, skin, and the gut.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Iain and Butcher, Mr John
Authors: Wenink, M.H., Santegoets, K.C.M., Butcher, J., van Bon, L., Lamers-Karnebeek, F.G.M., van den Berg, W.B., van Riel, P.L.C.M., McInnes, I.B., and Radstake, T.R.D.J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Dental School
Journal Name:Arthritis and Rheumatism
ISSN:0004-3591
Published Online:28 October 2011

University Staff: Request a correction | Enlighten Editors: Update this record